ALXN
Alexion Pharmaceuticals
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
517 hedge funds and large institutions have $30.2B invested in Alexion Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 192 increasing their positions, 210 reducing their positions, and 70 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
33% less first-time investments, than exits
New positions opened: 47 | Existing positions closed: 70
33% less funds holding in top 10
Funds holding in top 10: 21 → 14 (-7)
Holders
517
Holding in Top 10
14
Calls
$198M
Puts
$161M
Top Buyers
| 1 | +$260M | |
| 2 | +$130M | |
| 3 | +$79M | |
| 4 |
Millennium Management
New York
|
+$72.9M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$40.2M |
Top Sellers
| 1 | -$188M | |
| 2 | -$118M | |
| 3 | -$89.4M | |
| 4 |
Bank of New York Mellon
New York
|
-$77M |
| 5 |
Goldman Sachs
New York
|
-$59.6M |